Laura Jean Weston

This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Veroscience LLC, Santarus, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Jean Weston. Retrieved from https://idiyas.com/inventor/laura-jean-weston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 178(Granted Patents)

Company Filing History:

Years Active: 2013-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616693 - Bromocriptine formulations (2026-05-05),

2. 11666567 - Bromocriptine formulations (2023-06-06),

3. 11000522 - Bromocriptine formulations (2021-05-11),

4. 10688094 - Bromocriptine formulations (2020-06-23),

5. 10307421 - Bromocriptine formulations (2019-06-04),

6. 9993474 - Bromocriptine formulations (2018-06-12),

7. 9700555 - Bromocriptine formulations (2017-07-11),

8. 9522117 - Bromocriptine formulations (2016-12-20),

9. 9192576 - Bromocriptine formulations (2015-11-24),

10. 8993599 - Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them (2015-03-31),

11. 8613947 - Bromocriptine formulations (2013-12-24),

12. 8431155 - Bromocriptine formulations (2013-04-30),

Title: The Innovative Journey of Laura Jean Weston in Pharmaceutical Advancements

Introduction

Laura Jean Weston, an accomplished inventor based in Escondido, California, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 11 patents, she has demonstrated a strong commitment to advancing medical science, particularly in the management of diabetes.

Latest Patents

Among her notable inventions are her latest patents focused on bromocriptine formulations. These innovative pharmaceutical formulations of bromocriptine mesylate are designed to improve glycemic control in the treatment of type 2 diabetes. Her work outlines not only the formulation methods but also the effective usage of these formulations, highlighting her deep understanding of both chemistry and medicine.

Career Highlights

Laura has worked with prominent companies such as Veroscience LLC and Santarus, Inc., where she honed her skills and further developed her innovative ideas. Her career reflects a dedicated pursuit of excellence in drug formulation and therapeutic innovation, underscoring her significant role in the pharmaceutical landscape.

Collaborations

Throughout her career, Laura has collaborated with talented professionals, including Anthony H. Cincotta and Craig Michael Bowe. These partnerships have enabled her to combine expertise and insights, leading to groundbreaking developments in her field.

Conclusion

Laura Jean Weston’s continuous efforts in pharmaceutical innovation mark her as a standout inventor in her industry. Her latest work on bromocriptine formulations positions her as a pivotal figure in improving healthcare outcomes for individuals with type 2 diabetes. As she advances her research and patents, her contributions will undoubtedly leave a lasting impact on the field.

Profile summary based on public USPTO records.